The Discounted Cash Flow (DCF) valuation of THC Biomed Intl Ltd (THC.CN) is (10.76) CAD. With the latest stock price at 0.02 CAD, the upside of THC Biomed Intl Ltd based on DCF is -53878.1%.
Based on the latest price of 0.02 CAD and our DCF valuation, THC Biomed Intl Ltd (THC.CN) is a sell. selling THC.CN stocks now will result in a potential gain of 53878.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 3.9% - 4.5% | 4.2% |
| Long-term Growth Rate | 3.0% - 3.7% | 3.3% |
| Fair Price | (36.92) - (6.36) | (10.76) |
| Upside | -184675.8% - -31875.7% | -53878.1% |